MPR provides daily drug news and industry-supported drug information & education. Download our drug reference and clinical tools app today!
Joined August 2008
- Tweets 22,223
- Following 1,137
- Followers 3,726
- Likes 421
1,457 Photos and videos
📢 New MPR Pod out now!
💊 Once-weekly tablet promising for HIV;
👩 Weight loss drug efficacy assessed at all stages of menopause;
🔴 Hympavzi gains expanded indication; &
🏪 The FDA adds a warning label to an over-the-counter weight loss aid.
empr.com/news/mpr-weekly-dos…
17
In September, Illinois will become the 13th state (plus the District of Columbia) where medical aid in dying is legal. But the AMA says that “physician-assisted suicide is fundamentally incompatible with the physician’s role as healer”. empr.com/news/by-september-n…
1
26
Findings from a new trial showed an investigational once-daily Tx was statistically superior to deucravacitinib in reaching a Psoriasis Area and Severity Index of 100, at week 16. #psoriasis empr.com/news/zasocitinib-su…
1
19
Findings from an interim analysis of rilipruart showed that the study was unlikely to meet the efficacy threshold. empr.com/news/sanofi-halts-r…
36
A Tennessee case demonstrates failure of AI drug diversion software used in hundreds of US hospitals with little transparency or oversight. #AI #AISoftware #Sentri7 empr.com/news/at-a-tennessee…
13
First new active ingredient in more than 20 years added to US sunscreen. #Dermatology empr.com/news/bemotrizinol-n…
12
Doctors who manage maternity care will start charging à la carte for visits and services related to pregnancy, childbirth and postpartum care. empr.com/news/upcoming-billi…
13
This post-hox analyses evaluated 465 women across different menopausal stages. #orforglipron #Foundayo empr.com/news/orforglipron-w…
42
The US Department of Health and Human Services is seeking data from state systems that allow hospitals and clinics to exchange detailed, identifiable patient information. empr.com/news/rfk-jr-seeks-t…
7
🗣️ New MPR #Podcast out now! This week:
🦠 New Tx approved for cUTI;
🔹 Xocova approved for COVID-19 PEP;
👁️ Diabetic macular edema eye drops;
🔸 Afrezza expanded for ped use; and
🔹 Obefazimod looks promising for ulcerative colitis.
empr.com/news/mpr-weekly-dos…
69
All the notable drug pipeline updates that occurred in May in one easy-to-read table. #DrugsInThePipeline empr.com/news/may-2026-notab…
24
A Trump executive order is calling for the CDC and its Advisory Committee to review a HHS assessment and to "take any appropriate steps to update the US childhood and adolescent vaccine schedule." #VaccineSchedule empr.com/news/trump-signs-or…
31
Adjuvant therapy for early breast cancer is granted Priority Review. Target decision date of November 30, 2026 set for the application. empr.com/news/fda-priority-r…
9
First postexposure COVID-19 prophylaxis gains FDA approval. A trial showed that Xocova significantly reduced the likelihood of developing symptoms following exposure by 67% compared with placebo. #COVID19 empr.com/news/ensitrelvir-ap…
54
Afrezza Inhalation Powder is now approved for pediatric patients aged 6 years and older, providing a noninvasive mealtime insulin option. #Diabetes empr.com/news/afrezza-inhale…
20
Tremfya labelling updated to include data indicating the treatment inhibits the progression of structural joint damage in adults with active psoriatic arthritis. #PsoriaticArthritis empr.com/news/fda-tremfya-la…
37
🎧 New MPR Pod out now!
🔹 Novel Tx shows significant weight loss;
🔸 Hep delta virus Tx given accelerated approval;
🏪 Acne gel gains OTC designation;
🔹 Constipation Tx indication expanded; &
🔸 FDA extends review for camizestrant. #Podcast #PharmaPod
empr.com/news/mpr-weekly-dos…
1
66
Study finds tirzepatide superior to intensified conventional care for mean changes in hemoglobin A1c, weight, and waist circumference. empr.com/news/tirzepatide-su…
40
The FDA has extended the review for an investigational advanced breast cancer Tx Camizestrant after the Advisory Committee voted 6 to 3 against recommending approval. empr.com/news/fda-extends-ca…
56
Trial finds single consolidated infusion of Briumvi comparable to current schedule of multiple doses. #Pipeline #MultipleSclerosis empr.com/news/consolidated-u…
1
20